Aier Eye Hospital Group Co., Ltd. (300015.SZ)
CNY 12.98
(-0.15%)
CNY 12.98
(-0.15%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.98 Billion CNY | 15.64% |
| 2022 | 3.44 Billion CNY | 9.15% |
| 2021 | 3.15 Billion CNY | 128.26% |
| 2020 | 1.38 Billion CNY | -15.51% |
| 2019 | 1.63 Billion CNY | 23.92% |
| 2018 | 1.31 Billion CNY | -10.03% |
| 2017 | 1.46 Billion CNY | 688.53% |
| 2016 | 186.05 Million CNY | 6.81% |
| 2015 | 174.2 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | -100.0% |
| 2011 | 64 Million CNY | 0.0% |
| 2010 | 64 Million CNY | 0.0% |
| 2009 | 64 Million CNY | 0.0% |
| 2008 | 64 Million CNY | 0.0% |
| 2007 | 64 Million CNY | 0.0% |
| 2006 | 64 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.94 Billion CNY | -73.47% |
| 2024 Q2 | 4.83 Million CNY | -17.79% |
| 2024 Q3 | 56.88 Million CNY | 1076.04% |
| 2023 Q1 | 3.66 Billion CNY | 6.42% |
| 2023 Q3 | 3.58 Billion CNY | 1.75% |
| 2023 Q4 | 3.98 Billion CNY | 11.18% |
| 2023 FY | 3.98 Billion CNY | 15.64% |
| 2023 Q2 | 3.51 Billion CNY | -3.95% |
| 2022 Q2 | 3.15 Billion CNY | -3.84% |
| 2022 Q3 | 3.04 Billion CNY | -3.35% |
| 2022 Q1 | 3.27 Billion CNY | 3.9% |
| 2022 FY | 3.44 Billion CNY | 9.15% |
| 2022 Q4 | 3.44 Billion CNY | 13.04% |
| 2021 FY | 3.15 Billion CNY | 128.26% |
| 2021 Q2 | 4.1 Billion CNY | -4.34% |
| 2021 Q4 | 3.15 Billion CNY | -20.55% |
| 2021 Q3 | 3.97 Billion CNY | -3.17% |
| 2021 Q1 | 4.28 Billion CNY | 210.18% |
| 2020 FY | 1.38 Billion CNY | -15.51% |
| 2020 Q4 | 1.38 Billion CNY | -22.38% |
| 2020 Q3 | 1.78 Billion CNY | 0.2% |
| 2020 Q2 | 1.77 Billion CNY | -0.61% |
| 2020 Q1 | 1.78 Billion CNY | 9.29% |
| 2019 FY | 1.63 Billion CNY | 23.92% |
| 2019 Q1 | 1.24 Billion CNY | -5.97% |
| 2019 Q2 | 1.15 Billion CNY | -6.57% |
| 2019 Q3 | 73.91 Million CNY | -93.63% |
| 2019 Q4 | 1.63 Billion CNY | 2112.99% |
| 2018 Q2 | 1.41 Billion CNY | 0.0% |
| 2018 Q4 | 1.31 Billion CNY | -1.75% |
| 2018 FY | 1.31 Billion CNY | -10.03% |
| 2018 Q1 | 1.41 Billion CNY | -3.38% |
| 2018 Q3 | 1.34 Billion CNY | -5.22% |
| 2017 Q1 | 184.66 Million CNY | -0.75% |
| 2017 FY | 1.46 Billion CNY | 688.53% |
| 2017 Q4 | 1.46 Billion CNY | -16.06% |
| 2017 Q3 | 1.74 Billion CNY | 480.49% |
| 2017 Q2 | 301.11 Million CNY | 63.06% |
| 2016 FY | 186.05 Million CNY | 6.81% |
| 2016 Q3 | 174.2 Million CNY | 0.0% |
| 2016 Q2 | 174.2 Million CNY | 0.0% |
| 2016 Q1 | 174.2 Million CNY | 0.0% |
| 2016 Q4 | 186.05 Million CNY | 6.81% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 174.2 Million CNY | 0.0% |
| 2015 Q4 | 174.2 Million CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 Q4 | - CNY | -100.0% |
| 2012 Q1 | 64 Million CNY | 0.0% |
| 2012 FY | - CNY | -100.0% |
| 2012 Q2 | 64 Million CNY | 0.0% |
| 2012 Q3 | 64 Million CNY | 0.0% |
| 2011 FY | 64 Million CNY | 0.0% |
| 2011 Q4 | 64 Million CNY | 0.0% |
| 2011 Q2 | 64 Million CNY | 0.0% |
| 2011 Q1 | 64 Million CNY | 0.0% |
| 2011 Q3 | 64 Million CNY | 0.0% |
| 2010 Q2 | 64 Million CNY | 0.0% |
| 2010 Q4 | 64 Million CNY | 0.0% |
| 2010 FY | 64 Million CNY | 0.0% |
| 2010 Q1 | 64 Million CNY | 0.0% |
| 2010 Q3 | 64 Million CNY | 0.0% |
| 2009 FY | 64 Million CNY | 0.0% |
| 2009 Q4 | 64 Million CNY | 0.0% |
| 2009 Q2 | 64 Million CNY | 0.0% |
| 2009 Q3 | 64 Million CNY | 0.0% |
| 2008 Q4 | 64 Million CNY | 0.0% |
| 2008 FY | 64 Million CNY | 0.0% |
| 2007 FY | 64 Million CNY | 0.0% |
| 2006 FY | 64 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 4.61 Billion CNY | 13.679% |
| Meinian Onehealth Healthcare Holdings Co., Ltd. | 121.99 Million CNY | -3163.628% |